MedPath

Pain relieving strategies in Fibromyalgia Patients

Not Applicable
Conditions
Health Condition 1: null- Fibromyalgia patients with chronic pain
Registration Number
CTRI/2013/12/004228
Lead Sponsor
AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Adult females (age 18-50 years) diagnosed with Fibromyalgia

Exclusion Criteria

a) Pregnant and lactating mothers.

b) Concomitant diseases such as osteomalacia, metabolic bone diseases, hyperthyroidism, and other chronic diseases.

c) When medicines such as analgesics, anti-inflammatory or psychotropic cannot be stopped for even two days.

d) A history of seizures, brain trauma, brain surgery or intracranial hypertension, pace maker or other metallic implants

e) Contra-indications for TMS

f) Inflammation in the joints

h) abnormal levels of luteinizing hormone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The decrease in LH level in response to sucrose challenge test is deranged in fibromyalgia patients <br/ ><br> <br/ ><br>The nociceptive flexion reflex/R-III and other objective methods of pain are affected by rTMSTimepoint: Outcome name:Oral sucrose challenge test, 25gm/100 ml, pre and post rTMS, Time points:5 weeks <br/ ><br> <br/ ><br>Outcome name: Determination of Pain threshold and latency, pre and post rTMS,Time points: 5 weeks <br/ ><br> <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Pain in fibromyalgia is mediated by opioids <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>rTMS is effective therapy for treatment of fibromyalgiaTimepoint: Outcome name:Oral sucrose challenge test, 25gm/100 ml, pre and post rTMS, Time points:6 months, 1 year <br/ ><br> <br/ ><br>Outcome name: rTMS, 30 min/day/20 sessions, Time points:4 weeks
© Copyright 2025. All Rights Reserved by MedPath